Cargando…
Characterization of Alpelisib in Rat Plasma by a Newly Developed UPLC-MS/MS Method: Application to a Drug-Drug Interaction Study
Alpelisib, an oral selective and small-molecule phosphoinositide 3-kinase inhibitor, was lately approved in the United States to treat breast cancer. A sensitive method to quantify alpelisib levels in rat plasma on the basis of ultra-performance liquid chromatography–tandem mass spectrometry techniq...
Autores principales: | Wang, Qiong, Lan, Xia, Zhao, Zhuofei, Su, Xiaohang, Zhang, Yuji, Zhou, Xiao-Yang, Xu, Ren-Ai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656162/ https://www.ncbi.nlm.nih.gov/pubmed/34899297 http://dx.doi.org/10.3389/fphar.2021.743411 |
Ejemplares similares
-
Effect of Sophocarpine on the Pharmacokinetics of Umbralisib in Rat Plasma Using a Novel UPLC-MS/MS Method
por: Weng, Qinghua, et al.
Publicado: (2022) -
In vivo Pharmacokinetic Drug-Drug Interaction Studies Between Fedratinib and Antifungal Agents Based on a Newly Developed and Validated UPLC/MS-MS Method
por: Tang, Congrong, et al.
Publicado: (2021) -
UPLC-MS/MS Technology for the Quantitative Methodology and Pharmacokinetic Analysis of Voxtalisib in Rat Plasma
por: Li, Qingqing, et al.
Publicado: (2022) -
Development of a UPLC-MS/MS method for the determination of lacosamide and its metabolite and its application to drug-drug interaction
por: Chen, Jie, et al.
Publicado: (2023) -
Development of a UPLC-MS/MS method for the determination of orelabrutinib in rat plasma and its application in pharmacokinetics
por: Liu, Ya-nan, et al.
Publicado: (2022)